查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1362999

生物技術設備市場規模、佔有率和趨勢分析報告：2023-2030 年按產品、最終用途和細分市場分類的趨勢

Biotechnology Instruments Market Size, Share & Trends Analysis Report By Product (Cell Culture Instruments, Analytical Instruments), By End-use (Pharma & Biotech Companies, Academic & Research Institutes), And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

生物技術設備市場成長與趨勢：

根據Grand View Research, Inc.最新報告，預計到2030年，全球生物技術設備市場規模將達到1,166.8億美元，2023年至2030年年複合成長率為3.94%。

生命科學研究技術的進步、對個體化藥物和診斷測試的需求不斷增加，以及針對癌症等疾病的藥物和疫苗開發的增加，正在推動市場成長。政府不斷配合措施建立門診護理模式以縮短住院時間，以及家庭和醫療環境對 POC 設備的需求不斷成長，以滿足人口老化的需求，這推動了對 POC 診斷的需求。受以下要素影響：

此外，生物技術產業的擴張與多種要素有關，包括新的創新產品的引入、協議、收購、技術進步以及各種用途的採用增加。 2023 年 5 月，印度新興企業NeoDx Biotech Labs 推出了七種基於即時 PCR 的試劑盒，用於診斷丙型肝炎、乙型肝炎和愛滋病毒感染疾病，這些試劑盒正在各醫院和診斷中心使用。同樣，2023 年 1 月，Bio-Rad 宣布推出其即時 PCR 系統 CFX Opus Deepwell Dx，並獲得 FDA IVD 測試許可。因此，這些技術的推出預計將推動這段時期的市場成長。此外，該公司正在推出新產品，以促進更好、更先進的定序技術。

例如，2023年4月，Biomodal（原Cambridge Epigenetix）宣布推出其二重整學解決方案。預計這種新的多組學定序技術將突顯從單一小樣本中提取的遺傳和表觀遺傳見解的協同潛力。此外，該解決方案是首批單鹼基解析度定序技術之一，允許從單一樣本中同時階段讀出遺傳和表觀遺傳細節。這擴展了該技術在與任何定序平台整合的工作流程中的應用。測序技術的進步預計將推動市場成長。

生物技術設備市場報告亮點

  • 從按產品來看，分析儀器領域在2022年佔據市場主導地位，佔有率為61.92%。
  • 預計對先進藥物開發、生物標記發現和藥品品管的需求不斷成長將推動該領域在預測期內的成長。
  • 依最終用途，製藥和生技公司佔最大市場佔有率，2022年將達38.10%。
  • 這是由於癌症等各種疾病的藥物治療、疫苗開發以及用於疾病監測和檢測的診斷工具的設計的增加。
  • 2022年，由於大公司的存在和強大的醫療基礎設施，北美以43.95%的佔有率主導市場。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 變數、趨勢、範圍

  • 市場體系預測
  • 市場趨勢及展望
  • 市場動態
  • 市場抑制因素分析
  • 營商環境分析

第4章 產品經營分析

  • 生物技術設備市場：產品變化分析
  • 分析設備
    • 聚合酶鍊式反應
    • 光譜學
    • 顯微鏡檢查
    • 色譜法
    • 流式細胞儀
    • 定序
    • 微陣列
    • 其他
  • 細胞培養設備
    • 文化體系
    • 培養箱
    • 低溫儲存裝置
    • 生物安全設備
    • 移液器設備
  • 細胞分離設備
    • 離心式
    • 過濾系統
    • 磁激活細胞分離系統
  • 免疫檢測設備
  • 臨床生化分析儀
  • 其他

第5章 最終用途業務分析

  • 生物技術設備市場：最終用途變化分析
  • 製藥和生物技術公司
  • 醫院/診斷實驗室
  • 學術/研究機構
  • 其他

第6章 區域業務分析

  • 區域市場概述
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 西班牙
    • 法國
    • 義大利
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 泰國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭形勢

  • 公司分類
  • 策略規劃
  • 2022 年公司市場佔有率分析
  • 公司簡介/名單
    • Thermo Fisher Scientific, Inc.
    • Waters Corp.
    • Shimadzu Corp.
    • Danaher
    • Agilent Technologies, Inc.
    • Bruker Corp.
    • PerkinElmer, Inc.
    • Mettler Toledo
    • Zeiss Group
    • Bio-Rad Laboratories, Inc.
    • Illumina, Inc.
    • Eppendorf SE
    • F. Hoffmann-La Roche AG
    • Sartorius AG
    • Avantor, Inc.
Product Code: GVR-4-68039-625-9

Biotechnology Instruments Market Growth & Trends:

The global biotechnology instruments market size is expected to reach USD 116.68 billion by 2030, according to a new report by Grand View Research, Inc.., exhibiting a CAGR of 3.94% from 2023 to 2030. The growing advancements in life science research technologies, growing demand for personalized medicines & diagnostics tests, and rising R&D for drug & vaccine developments for diseases, such as cancer, collectively propel the market growth. The demand for POC diagnostics is projected to be driven by factors, such as increasing government initiatives to establish outpatient care models for shortening hospital stays and the rising need for POC devices in home & healthcare settings to address the needs of the elderly population.

In addition, the expansion of the biotechnology industry can be linked to various factors including the introduction of new & innovative products, agreements, acquisitions, technological advancements, and growing adoption across different applications. In May 2023, NeoDx Biotech Labs, an Indian startup, launched 7 real-time PCR-based kits to diagnose infectious diseases, such as Hepatitis C, Hepatitis B, and HIV, at various hospitals and diagnostic centers. Similarly, in January 2023, Bio-Rad announced the launch of a real-time PCR system, CFX Opus Deepwell Dx, which is FDA-approved for IVD testing. Thus, these technological launches are projected to impel the market growth over the period. In addition, companies are launching new products to facilitate better and more advanced sequencing technology.

For instance, in April 2023, Biomodal, formerly known as Cambridge Epigenetix, announced the launch of the duet multiomics solution. This new multiomics sequencing technology is projected to highlight the synergistic potential of genetic and epigenetic insights extracted from a single low-volume sample. Moreover, the solution is one of the first single-base-resolution sequencing technologies, which enables simultaneous, phased reading of both genetic and epigenetic details from a single sample. This increases applications of the technology in unified workflows alongside any sequencing platforms. The increasing adoption of technological advancements in sequencing techniques is anticipated to impel market growth.

Biotechnology Instruments Market Report Highlights:

  • Based on product, the analytical instruments segment dominated the market in 2022 with a share of 61.92%
  • The growing demand for advanced drug development, biomarker discovery, and quality control across pharmaceuticals is anticipated to fuel the segment growth over the forecast period
  • Based on end-use, the pharmaceutical & biotechnological companies segment held the largest market share of 38.10% in 2022
  • This can be attributed to the increased number of drug therapies for various diseases, such as cancer, vaccine developments, and designing diagnostic tools for disease monitoring & detection
  • In 2022, North America dominated the market with a share of 43.95% owing to the presence of major players and robust healthcare infrastructure

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. End-use Segment
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Formulation & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2
    • 1.9.3. Objective 3

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends And Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Increasing Demand For Analytical Instruments
    • 3.3.2. Growing Prevalence Of Target Diseases And Rising Geriatric Population
    • 3.3.3. Technological Advancements In Research-Use Instruments
  • 3.4. Market Restraint Analysis
    • 3.4.1. Higher Cost Of Devices
    • 3.4.2. Shortage Of Skilled Professionals
  • 3.5. Business Environment Analysis
    • 3.5.1. PESTEL Analysis
    • 3.5.2. Porter's Five Forces Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Biotechnology Instruments Market: Product Movement Analysis
  • 4.2. Analytical Instruments
    • 4.2.1. Analytical Instruments Market, 2018 - 2030 (USD Million)
    • 4.2.2. Polymerase Chain Reaction
      • 4.2.2.1. Polymerase Chain Reaction, 2018 - 2030 (USD Million)
    • 4.2.3. Spectroscopy
      • 4.2.3.1. Spectroscopy, 2018 - 2030 (USD Million)
    • 4.2.4. Microscopy
      • 4.2.4.1. Microscopy, 2018 - 2030 (USD Million)
    • 4.2.5. Chromatography
      • 4.2.5.1. Chromatography, 2018 - 2030 (USD Million)
    • 4.2.6. Flow Cytometry
      • 4.2.6.1. Flow Cytometry, 2018 - 2030 (USD Million)
    • 4.2.7. Sequencing
      • 4.2.7.1. Sequencing, 2018 - 2030 (USD Million)
    • 4.2.8. Microarray
      • 4.2.8.1. Microarray, 2018 - 2030 (USD Million)
    • 4.2.9. Others
      • 4.2.9.1. Others, 2018 - 2030 (USD Million)
  • 4.3. Cell Culture Instruments
    • 4.3.1. Cell Culture Instruments Market, 2018 - 2030 (USD Million)
    • 4.3.2. Culture Systems
      • 4.3.2.1. Culture Systems Market, 2018 - 2030 (USD Million)
    • 4.3.3. Incubators
      • 4.3.3.1. Incubators Market, 2018 - 2030 (USD Million)
    • 4.3.4. Cryostorage Equipment
      • 4.3.4.1. Cryostorage Equipment Market, 2018 - 2030 (USD Million)
    • 4.3.5. Biosafety Equipment
      • 4.3.5.1. Biosafety Equipment Market, 2018 - 2030 (USD Million)
    • 4.3.6. Pipetting Instruments
      • 4.3.6.1. Pipetting Instruments Market, 2018 - 2030 (USD Million)
  • 4.4. Cell Separation Instruments
    • 4.4.1. Cell Separation Instruments Market, 2018 - 2030 (USD Million)
    • 4.4.2. Centrifuge
      • 4.4.2.1. Centrifuge Market, 2018 - 2030 (USD Million)
    • 4.4.3. Filtration Systems
      • 4.4.3.1. Filtration Systems Market, 2018 - 2030 (USD Million)
    • 4.4.4. Magnetic-activated Cell Separator Systems
      • 4.4.4.1. Magnetic-activated Cell Separator Systems Market, 2018 - 2030 (USD Million)
  • 4.5. Immunoassay Instruments
    • 4.5.1. Immunoassay Instruments Market, 2018 - 2030 (USD Million)
  • 4.6. Clinical Chemistry Analyzers
    • 4.6.1. Clinical Chemistry Analyzers Market, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. End-use Business Analysis

  • 5.1. Biotechnology Instruments Market: End-use Movement Analysis
  • 5.2. Pharmaceutical & Biotechnology Companies
    • 5.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 5.3. Hospitals & Diagnostic Laboratories
    • 5.3.1. Hospitals & Diagnostics Laboratories Market, 2018 - 2030 (USD Million)
  • 5.4. Academic & Research Institutes
    • 5.4.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis

  • 6.1. Regional Market Snapshot
  • 6.2. North America
    • 6.2.1. North America Biotechnology Instruments Market, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.2.2.2. Key Country Dynamics
      • 6.2.2.3. Competitive Scenario
      • 6.2.2.4. Target Disease Prevalence
      • 6.2.2.5. Regulatory Framework
    • 6.2.3. Canada
      • 6.2.3.1. Canada Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.2.3.2. Key Country Dynamics
      • 6.2.3.3. Competitive Scenario
      • 6.2.3.4. Target Disease Prevalence
      • 6.2.3.5. Regulatory Framework
  • 6.3. Europe
    • 6.3.1. Europe Biotechnology Instruments Market, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.3.2.2. Key Country Dynamics
      • 6.3.2.3. Competitive Scenario
      • 6.3.2.4. Target Disease Prevalence
      • 6.3.2.5. Regulatory Framework
    • 6.3.3. Germany
      • 6.3.3.1. Germany Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.3.3.2. Key Country Dynamics
      • 6.3.3.3. Competitive Scenario
      • 6.3.3.4. Target Disease Prevalence
      • 6.3.3.5. Regulatory Framework
    • 6.3.4. Spain
      • 6.3.4.1. Spain Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.3.4.2. Key Country Dynamics
      • 6.3.4.3. Competitive Scenario
      • 6.3.4.4. Target Disease Prevalence
      • 6.3.4.5. Regulatory Framework
    • 6.3.5. France
      • 6.3.5.1. France Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.3.5.2. Key Country Dynamics
      • 6.3.5.3. Competitive Scenario
      • 6.3.5.4. Target Disease Prevalence
      • 6.3.5.5. Regulatory Framework
    • 6.3.6. Italy
      • 6.3.6.1. Italy Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.3.6.2. Key Country Dynamics
      • 6.3.6.3. Competitive Scenario
      • 6.3.6.4. Target Disease Prevalence
      • 6.3.6.5. Regulatory Framework
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.3.7.2. Key Country Dynamics
      • 6.3.7.3. Competitive Scenario
      • 6.3.7.4. Target Disease Prevalence
      • 6.3.7.5. Regulatory Framework
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.3.8.2. Key Country Dynamics
      • 6.3.8.3. Competitive Scenario
      • 6.3.8.4. Target Disease Prevalence
      • 6.3.8.5. Regulatory Framework
    • 6.3.9. Norway
      • 6.3.9.1. Norway Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.3.9.2. Key Country Dynamics
      • 6.3.9.3. Competitive Scenario
      • 6.3.9.4. Target Disease Prevalence
      • 6.3.9.5. Regulatory Framework
  • 6.4. Asia Pacific
    • 6.4.1. Asia-Pacific Biotechnology Instruments Market, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.4.2.2. Key Country Dynamics
      • 6.4.2.3. Competitive Scenario
      • 6.4.2.4. Target Disease Prevalence
      • 6.4.2.5. Regulatory Framework
    • 6.4.3. China
      • 6.4.3.1. China Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.4.3.2. Key Country Dynamics
      • 6.4.3.3. Competitive Scenario
      • 6.4.3.4. Target Disease Prevalence
      • 6.4.3.5. Regulatory Framework
    • 6.4.4. India
      • 6.4.4.1. India Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.4.4.2. Key Country Dynamics
      • 6.4.4.3. Competitive Scenario
      • 6.4.4.4. Target Disease Prevalence
      • 6.4.4.5. Regulatory Framework
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.4.5.2. Key Country Dynamics
      • 6.4.5.3. Competitive Scenario
      • 6.4.5.4. Target Disease Prevalence
      • 6.4.5.5. Regulatory Framework
    • 6.4.6. Thailand
      • 6.4.6.1. Thailand Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.4.6.2. Key Country Dynamics
      • 6.4.6.3. Competitive Scenario
      • 6.4.6.4. Target Disease Prevalence
      • 6.4.6.5. Regulatory Framework
    • 6.4.7. Australia
      • 6.4.7.1. Australia Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.4.7.2. Key Country Dynamics
      • 6.4.7.3. Competitive Scenario
      • 6.4.7.4. Target Disease Prevalence
      • 6.4.7.5. Regulatory Framework
  • 6.5. Latin America
    • 6.5.1. Latin America Biotechnology Instruments Market, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.5.2.2. Key Country Dynamics
      • 6.5.2.3. Competitive Scenario
      • 6.5.2.4. Target Disease Prevalence
      • 6.5.2.5. Regulatory Framework
    • 6.5.3. Mexico
      • 6.5.3.1. Mexico Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.5.3.2. Key Country Dynamics
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. Target Disease Prevalence
      • 6.5.3.5. Regulatory Framework
    • 6.5.4. Argentina
      • 6.5.4.1. Argentina Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.5.4.2. Key Country Dynamics
      • 6.5.4.3. Competitive Scenario
      • 6.5.4.4. Target Disease Prevalence
      • 6.5.4.5. Regulatory Framework
  • 6.6. MEA
    • 6.6.1. MEA Biotechnology Instruments Market, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.6.2.2. Key Country Dynamics
      • 6.6.2.3. Competitive Scenario
      • 6.6.2.4. Target Disease Prevalence
      • 6.6.2.5. Regulatory Framework
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.6.3.2. Key Country Dynamics
      • 6.6.3.3. Competitive Scenario
      • 6.6.3.4. Target Disease Prevalence
      • 6.6.3.5. Regulatory Framework
    • 6.6.4. UAE
      • 6.6.4.1. UAE Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.6.4.2. Key Country Dynamics
      • 6.6.4.3. Competitive Scenario
      • 6.6.4.4. Target Disease Prevalence
      • 6.6.4.5. Regulatory Framework
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.6.5.2. Key Country Dynamics
      • 6.6.5.3. Competitive Scenario
      • 6.6.5.4. Target Disease Prevalence
      • 6.6.5.5. Regulatory Framework

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Share Analysis, 2022
  • 7.4. Company Profiles/Listing
    • 7.4.1. Thermo Fisher Scientific, Inc.
      • 7.4.1.1. Company Overview
      • 7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Waters Corp.
      • 7.4.2.1. Company Overview
      • 7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Shimadzu Corp.
      • 7.4.3.1. Company Overview
      • 7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Danaher
      • 7.4.4.1. Company Overview
      • 7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Agilent Technologies, Inc.
      • 7.4.5.1. Company Overview
      • 7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Bruker Corp.
      • 7.4.6.1. Company Overview
      • 7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. PerkinElmer, Inc.
      • 7.4.7.1. Company Overview
      • 7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Mettler Toledo
      • 7.4.8.1. Company Overview
      • 7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Zeiss Group
      • 7.4.9.1. Company Overview
      • 7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. Bio-Rad Laboratories, Inc.
      • 7.4.10.1. Company Overview
      • 7.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives
    • 7.4.11. Illumina, Inc.
      • 7.4.11.1. Company Overview
      • 7.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Strategic Initiatives
    • 7.4.12. Eppendorf SE
      • 7.4.12.1. Company Overview
      • 7.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Strategic Initiatives
    • 7.4.13. F. Hoffmann-La Roche AG
      • 7.4.13.1. Company Overview
      • 7.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.13.3. Product Benchmarking
      • 7.4.13.4. Strategic Initiatives
    • 7.4.14. Sartorius AG
      • 7.4.14.1. Company Overview
      • 7.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.14.3. Product Benchmarking
      • 7.4.14.4. Strategic Initiatives
    • 7.4.15. Avantor, Inc.
      • 7.4.15.1. Company Overview
      • 7.4.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.15.3. Product Benchmarking
      • 7.4.15.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America biotechnology instruments market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 5 North America biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 U.S. biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 Canada biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 9 Canada biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 Europe biotechnology instruments market, by country, 2018 - 2030 (USD Million)
  • Table 11 Europe biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 12 Europe biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 UK biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 14 UK biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Germany biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 16 Germany biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 France biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 18 France biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Italy biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 20 Italy biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 21 Spain biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 22 Spain biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Denmark biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 24 Denmark biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Sweden biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 26 Sweden biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 Norway biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 28 Norway biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific biotechnology instruments market, by country, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 32 China biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 33 China biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Japan biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 35 Japan biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 36 India biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 37 India biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 South Korea biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 39 South Korea biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Australia biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 41 Australia biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 42 Thailand biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 43 Thailand biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Latin America biotechnology instruments market, by country, 2018 - 2030 (USD Million)
  • Table 45 Latin America biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 46 Latin America biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Brazil biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 48 Brazil biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Mexico biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 50 Mexico biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 Argentina biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 52 Argentina biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Middle East & Africa biotechnology instruments market, by country, 2018 - 2030 (USD Million)
  • Table 54 Middle East & Africa biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 South Africa biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 57 South Africa biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 UAE biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 61 UAE biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Kuwait biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 63 Kuwait biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global biotechnology instruments market - Key market driver analysis
  • Fig. 7 Global biotechnology instruments market - Key market restraint analysis
  • Fig. 8 Global biotechnology instruments market - Porter's analysis
  • Fig. 9 Global biotechnology instruments market - PESTEL analysis
  • Fig. 10 Global biotechnology instruments market: Product outlook key takeaways
  • Fig. 11 Global biotechnology instruments market: Product movement analysis
  • Fig. 12 Analytical instruments market estimates, 2018 - 2030 (USD Million)
  • Fig. 13 Polymerase chain reaction market estimates, 2018 - 2030 (USD Million)
  • Fig. 14 Spectroscopy market estimates, 2018 - 2030 (USD Million)
  • Fig. 15 Microscopy market estimates, 2018 - 2030 (USD Million)
  • Fig. 16 Chromatography market estimates, 2018 - 2030 (USD Million)
  • Fig. 17 Flow cytometry market estimates, 2018 - 2030 (USD Million)
  • Fig. 18 Sequencing market estimates, 2018 - 2030 (USD Million)
  • Fig. 19 Microarray market estimates, 2018 - 2030 (USD Million)
  • Fig. 20 Others market estimates, 2018 - 2030 (USD Million)
  • Fig. 21 Cell culture instruments market estimates, 2018 - 2030 (USD Million)
  • Fig. 22 Culture systems market estimates, 2018 - 2030 (USD Million)
  • Fig. 23 Incubators market estimates, 2018 - 2030 (USD Million)
  • Fig. 24 Cryostorage equipment market estimates, 2018 - 2030 (USD Million)
  • Fig. 25 Biosafety equipment market estimates, 2018 - 2030 (USD Million)
  • Fig. 26 Pipetting instruments market estimates, 2018 - 2030 (USD Million)
  • Fig. 27 Cell separation instruments market estimates, 2018 - 2030 (USD Million)
  • Fig. 28 Centrifuge market estimates, 2018 - 2030 (USD Million)
  • Fig. 29 Filtration systems market estimates, 2018 - 2030 (USD Million)
  • Fig. 30 Magnetic - activated cell separator systems market estimates, 2018 - 2030 (USD Million)
  • Fig. 31 Immnuoassay instruments market estimates, 2018 - 2030 (USD Million)
  • Fig. 32 Clinical chemistry analyzers market estimates, 2018 - 2030 (USD Million)
  • Fig. 33 Others market estimates, 2018 - 2030 (USD Million)
  • Fig. 34 Global biotechnology instruments market: End - use outlook key takeaways
  • Fig. 35 Global biotechnology instruments market: End - use movement analysis
  • Fig. 36 Pharmaceutical & biotechnology companies market estimates, 2018 - 2030 (USD Million)
  • Fig. 37 Hospitals & diagnostic laboratories market estimates, 2018 - 2030 (USD Million)
  • Fig. 38 Academic & research institutes market estimates, 2018 - 2030 (USD Million)
  • Fig. 39 Others market estimates, 2018 - 2030 (USD Million)
  • Fig. 40 Regional marketplace: Key takeaways
  • Fig. 41 Global biotechnology instruments market: Regional movement analysis
  • Fig. 42 North America biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 43 U.S. biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 44 Canada biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 45 Europe biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 46 UK biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 47 Germany biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 48 France biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 49 Spain biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 50 Italy biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 51 Denmark biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 52 Sweden biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 53 Norway biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 54 Asia Pacific biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 55 Japan biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 56 China biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 57 India biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 58 South Korea biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 59 Australia biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 60 Thailand biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 61 Latin America biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 62 Brazil biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 63 Mexico biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 64 Argentina biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 65 MEA biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 66 South Africa biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 67 Saudi Arabia biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 68 UAE biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 69 Kuwait biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 70 Strategy framework